OmniAb, Inc. offers a discovery platform that provides pharmaceutical industry partners with access to diverse antibody repertoires and high-throughput screening technologies to enable the discovery of next-generation therapeutics. The OmniAb platform is the biological intelligence (BI) of transgenic animals, including OmniRat, OmniChicken, and OmniMouse, which have been genetically modified to generate antibodies with human sequences to facilitate the development of human therapeutic candidates. We show 3 historical shares outstanding datapoints in our OABI shares outstanding history coverage, used to compute OABI market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing OABI market cap history over the course of time is important for investors
interested in comparing OABI's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of OABI versus a peer is one thing; comparing
OABI market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like OABI can fluctuate over the course of history.
With this page we aim to empower investors researching OABI by allowing them to research the OABI market cap history. |
Free OABI Email Alerts:
Video: The Importance of Market Cap
